We would love to hear your thoughts about our site and services, please take our survey here.
It's not about today or tomorrows price. It is the price if we sell the Company. Example, if SCLP sell for £500m and there are 500m shares they are £1 each. If we sell for £500m and there are 1billion shares it is only 50p each. Diluted no matter how you look at it we own a smaller piece of the Company. Fact nothing anyone say to change it. Whatever price SCLP sell for you get a smaller cut the more shares in issue.
80p last Friday to just over 93p today. I would like to get to £1.10 before results to build from after results released for Q1. I do think we may start to see people taking profit so this could slow the price rise down over the next week or so but hope I am wrong. £1.50 by year end could be seen.
https://www.bbc.com/news/health-53426367
To deliberately expose people to a potentially deadly illness.
There won't be an AGM this year in the usual format certainly not face to face in any conference facility. It will go the way of most other companies on line with questions submitted in advance. The BOD will not miss the opportunity COVID 19 has presented them to avoid being fully held to account, same as most other companies. IMO.
29th July as per the PFD web site.
https://www.bbc.co.uk/news/business-53284788
Tesco at it again. Didn’t PFD have a fall out with Tesco in the past over discounts?
Are PFD still due to release a formal Q1 trading update in the next few weeks. They normally come out in mid July. If so this could give another lift to the share price as it should be a great Q1 from lockdown.
Prof Jonathan Ball in the below BBC article
https://www.bbc.com/news/live/world-52553430/page/6
James Gallagher
BBC News, Health and science correspondent
Is coronavirus mutating to become weaker, or more contagious, or is it too soon to tell? All three interpretations are news stories doing the rounds.
The coronavirus is certainly mutating - viruses do it all the time. The issue is most of those changes will not alter the behaviour of the virus at all.
So far scientists have analysed the genetic code of the virus, but have not then tested whether they are meaningful in the laboratory.
“I love genomes, but there is only so much they can say,” said Dr Lucy Van Dorp, whose research at UCL has identified nearly 200 mutations that seem to be regularly occurring in the coronavirus.
A mutation to the critical “spike protein” that the virus uses as a key to get inside our body’s cells is attracting significant attention. The mutation is widespread – that could be because it is making the virus more contagious or it could be random chance.
“At the moment we have no biology whatsoever, it’s a very interesting observation that is worthwhile following up, but at the moment it is no more than that,” Prof Jonathan Ball from the University of Nottingham told me.
Understanding mutation is vital. It will tell us if the coronavirus is becoming more or less of a threat, if immunity will last, and inform vaccine and drug research.